Daniel Gil-Alós

Statistics

Publications

Citations

141

H-Index

Active since

2020

Affiliations

Research Institute Hospital 12 de Octubre(Current)

University of Florida Health

Emory University

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, San Francisco

Daniel Gil-Alós is an author at Research Institute Hospital 12 de Octubre specializing in hematologic malignancy risk, cancer mortality, and infection risk factors.

ORCID

Publications per year

2020–2025

Publications

Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies

José María Sánchez‐Pina, Mario Rodríguez, Nerea Castro Quismondo et al. · European Journal Of Haematology · 2020 · 96 citations

Medicine, Hematology, Infectious Diseases +10

Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network

A. Sanz, Rosa Ayala, Gema Hernández et al. · Blood Cancer Journal · 2022 · 23 citations · Full text

Pharmacy, Health Informatics, Oncology +17

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar et al. · Blood · 2025 · 12 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 10 citations · Full text

Life Sciences, Immunology, Oncology +16

1–4 of 4